<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hodge</surname>
    <given-names>R. A. V.</given-names>
   </name>
   <name>
    <surname>Sutton</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Boyd</surname>
    <given-names>M. R.</given-names>
   </name>
   <name>
    <surname>Harnden</surname>
    <given-names>M. R.</given-names>
   </name>
   <name>
    <surname>Jarvest</surname>
    <given-names>R. L.</given-names>
   </name>
  </person-group> (
  <year>1989</year>). 
  <article-title>Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; penciclovir].</article-title>
  <source>
   <italic>Antimicrob. Agents Chemother.</italic>
  </source>
  <volume>33</volume>
  <fpage>1765</fpage>â€“
  <lpage>1773</lpage>. 
  <pub-id pub-id-type="doi">10.1128/aac.33.10.1765</pub-id>
  <?supplied-pmid 2589844?>
  <pub-id pub-id-type="pmid">2589844</pub-id>
 </mixed-citation>
</ref>
